Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

DocGo Acquires Virtual Care Platform SteadyMD; No Financial Terms Disclosed; In 2025, SteadyMD Is Expected To Generate ~$25M In Revenue And Is Expected To Be EBITDA Positive For 2026

Author: Benzinga Newsdesk | October 20, 2025 04:23pm

Strategic Acquisition Combines DocGo's Last Mile Healthcare Delivery Capabilities With SteadyMD's Virtual Care Platform; SteadyMD Is Expected To Generate Approximately $25 Million in Revenue in 2025*

DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it has acquired virtual care platform SteadyMD, Inc. Management will host a conference call and webcast on Tuesday, October 21 at 11:00 a.m. ET to discuss this acquisition.

SteadyMD powers high-quality telehealth experiences for digital health companies, labs, pharmacies, employers, and other healthcare innovators. The company offers a 50-state virtual clinician workforce, clinical operations, and world-class technology that powers real-time matching between patient needs and clinical expertise. SteadyMD provides virtual care for top consumer, healthcare and digital wellness brands, including multiple Fortune 10 customers. SteadyMD is expected to service over 3 million patients in 2025, and maintains a roster of over 600 clinicians. SteadyMD's scaled network of virtual providers will enable DocGo to achieve more efficient delivery of patient care by pairing its mobile health clinicians in the field with SteadyMD's clinical network.

In 2025, SteadyMD is expected to generate approximately $25 million in revenue and is expected to be EBITDA positive for 2026*. The Company plans to update 2025 revenue and adjusted EBITDA guidance to reflect the transaction as part of its upcoming earnings release and call, which is expected to be held in early November. Guy Friedman, CEO and Co-Founder of SteadyMD, and Yarone Goren, COO and Co-Founder of SteadyMD, are joining the DocGo leadership team upon the close of the transaction.

Posted In: DCGO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist